Foran J - Search Results

1

Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.

Fayad L, Offner F, Smith MR, Verhoef G, Johnson P, Kaufman JL, Rohatiner A, Advani A, Foran J, Hess G, Coiffier B, Czuczman M, Giné E, Durrant S, Kneissl M, Luu KT, Hua SY, Boni J, Vandendries E, Dang NH. Fayad L, et al. Among authors: foran j. J Clin Oncol. 2013 Feb 10;31(5):573-83. doi: 10.1200/JCO.2012.42.7211. Epub 2013 Jan 7. J Clin Oncol. 2013. PMID: 23295790 Free PMC article. Clinical Trial.

2

High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre.

Foran JM, Apostolidis J, Papamichael D, Norton AJ, Matthews J, Amess JA, Lister TA, Rohatiner AZ. Foran JM, et al. Ann Oncol. 1998 Aug;9(8):865-9. doi: 10.1023/a:1008349427337. Ann Oncol. 1998. PMID: 9789609 Free article. Clinical Trial.

3

Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.

Foran JM, Rohatiner AZ, Coiffier B, Barbui T, Johnson SA, Hiddemann W, Radford JA, Norton AJ, Tollerfield SM, Wilson MP, Lister TA. Foran JM, et al. J Clin Oncol. 1999 Feb;17(2):546-53. doi: 10.1200/JCO.1999.17.2.546. J Clin Oncol. 1999. PMID: 10080598 Clinical Trial.

4

Peripheral T-cell lymphoma following rituximab therapy for B-cell lymphoma.

Micallef IN, Kirk A, Norton A, Foran JM, Rohatiner AZ, Lister TA. Micallef IN, et al. Among authors: foran jm. Blood. 1999 Apr 1;93(7):2427-8. Blood. 1999. PMID: 10215354 Free article. No abstract available.

5

Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.

Foran JM, Oscier D, Orchard J, Johnson SA, Tighe M, Cullen MH, de Takats PG, Kraus C, Klein M, Lister TA. Foran JM, et al. J Clin Oncol. 1999 May;17(5):1574-9. doi: 10.1200/JCO.1999.17.5.1574. J Clin Oncol. 1999. PMID: 10334546 Clinical Trial.

6

Patterns of outcome following recurrence after myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma.

Apostolidis J, Foran JM, Johnson PW, Norton A, Amess J, Matthews J, Bradburn M, Lister TA, Rohatiner AZ. Apostolidis J, et al. Among authors: foran jm. J Clin Oncol. 1999 Jan;17(1):216-21. doi: 10.1200/JCO.1999.17.1.216. J Clin Oncol. 1999. PMID: 10458236

7

Immunocytoma: a retrospective analysis from St Bartholomew's Hospital-1972 to 1996.

Papamichael D, Norton AJ, Foran JM, Mulatero C, Mathews J, Amess JA, Bradburn M, Lister TA, Rohatiner AZ. Papamichael D, et al. Among authors: foran jm. J Clin Oncol. 1999 Sep;17(9):2847-53. doi: 10.1200/JCO.1999.17.9.2847. J Clin Oncol. 1999. PMID: 10561361

8

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.

Foran JM, Rohatiner AZ, Cunningham D, Popescu RA, Solal-Celigny P, Ghielmini M, Coiffier B, Johnson PW, Gisselbrecht C, Reyes F, Radford JA, Bessell EM, Souleau B, Benzohra A, Lister TA. Foran JM, et al. J Clin Oncol. 2000 Jan;18(2):317-24. doi: 10.1200/JCO.2000.18.2.317. J Clin Oncol. 2000. PMID: 10637245 Clinical Trial.

9

Micallef IN, Lillington DM, Apostolidis J, Amess JA, Neat M, Matthews J, Clark T, Foran JM, Salam A, Lister TA, Rohatiner AZ. Micallef IN, et al. Among authors: foran jm. J Clin Oncol. 2000 Mar;18(5):947-55. doi: 10.1200/JCO.2000.18.5.947. J Clin Oncol. 2000. PMID: 10694543

10

Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response.

Foran JM, Cunningham D, Coiffier B, Solal-Celigny P, Reyes F, Ghielmini M, Johnson PW, Gisselbrecht C, Bradburn M, Matthews J, Lister TA. Foran JM, et al. Ann Oncol. 2000;11 Suppl 1:117-21. Ann Oncol. 2000. PMID: 10707792

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

309 results

Search Page

Filters